Tuesday, 18 February 2020

Japan News

  • Takara Bio enters deal with Invivoscribe

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 06 Dec, 2012

    Singapore: Japanese firm Takara Bio has entered into an agreement with Invivoscribe Technologies to grant the latter licenses to facilitate and conduct patent-covered tests for the presence...Read more

  • NuVasive spine surgery implant approved in Japan

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 19 Dec, 2012

    Singapore: NuVasive, a medical device company focused on developing minimally disruptive surgical products and procedures for the spine, has received Japan's approval of the CoRoent Large ...Read more

  • Mitsubishi to acquire Medicago at $1.16 per share

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 17 Jul, 2013

    Singapore: Medicago, a biopharmaceutical company focused on developing highly effective and competitive vaccines based on proprietary manufacturing technologies and virus-like particles (VL...Read more

  • Kinetic launches portable negative pressure therapy

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 10 Apr, 2013

    Singapore: US-based Kinetic Concepts (KCI) has launched ActiVAC Therapy System for in-patient use in Japan, which is a lightweight, portable negative pressure therapy system that makes usin...Read more

  • Terumo and Biosensors to sell Nabori DES system

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2012

    Singapore: Terumo and Biosensors International announced an extension of their existing licensing agreements, under which Terumo can continue to incorporate BioMatrix technology in the...Read more

  • Otsuka, Lundbeck files NDA for schizophrenia drug

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 15 Jul, 2014

    Singapore: Japanese firm Otsuka Pharmaceutical and global firm H Lundbeck have submitted a New Drug Application (NDA) to the United States Food and Drug Administration (FDA) for brexpiprazo...Read more

  • HealthPatch MD receives Japanese nod

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 19 Feb, 2015

    Singapore: Vital Connect recently announced that its wearable device HealthPatch MD has received approval for sale in the Japanese markets. The device has received, Medical Device Ninsho ce...Read more

  • Amgen-Cytokinetics collaboration to include Japan

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 17 Jun, 2013

    Singapore: USA-based Amgen, the world's largest independent biotech company, has expanded its strategic collaboration with Cytokinetics to include Japan. In 2006, Cytokinetics and Amgen ent...Read more

  • Taiho seeks Japanese nod for oral cancer agent

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 28 Feb, 2013

    Singapore: Taiho Pharmaceutical submitted an application for approval of the manufacture and marketing of the novel oral nucleoside antitumor agent TAS-102 (combination of trifluorothymidin...Read more

  • FDA approves Eisai's Fycompa

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2012

    Singapore: Eisai announced that its U.S. subsidiary has received approval from the U.S. Food and Drug Administration (FDA) for the AMPA receptor antagonist Fycompa® (perampanel) as an adj...Read more

  • Innovative dual chamber syringe for pharma market

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 05 Jun, 2012

    Singapore: Japan-based Arte and German company ProJect Pharmaceutics are working closely on the development of a new type of dual chamber prefillable syringe for freeze-dried pharmaceutical...Read more

  • Takeda to acquire LigoCyte Pharma

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2012

    Singapore: Takeda Pharmaceutical Company and LigoCyte Pharmaceuticals, jointly announced that Takeda's wholly-owned subsidiary, Takeda America Holdings and LigoCyte Pharmaceuticals have en...Read more

  • BioJapan to kick off in October

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2012

    Singapore: The 17th edition of BioJapan is all set to kick off from October 14, 2015 Pacifico Yokohama. Top industry players from more than 30 countries are expected to gather at the Asia's...Read more

  • Takeda, Resolve to develop, sell autoimmune drugs

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 28 Feb, 2013

    Singapore: Takeda Pharmaceutical has entered into a partnership with Resolve Therapeutics to develop compounds for the treatment of lupus (also known as systemic lupus erythematosus or SLE)...Read more

  • Takeda acquires LigoCyte Pharmaceuticals at $60 mn

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2012

    Singapore: LEO Pharma plans to establish five long-term, strategic research collaborations in four countries by the end of next year. The ambitious initiative aims to deliver new treatment ...Read more

  • GlobalData: Osteoporosis market to be $8 bn

    Japan |  Analysis | By BioSpectrum Bureau  | 0 Comment | 08 Mar, 2013

    Singapore: According to GlobalData, the osteoporosis therapeutics market of the US, France, Germany, Italy, Spain, the UK, Japan, China, and India will reach a value of $8 billion in 2022 ...Read more

  • R-Tech Ueno loses case against Takeda

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 09 Jul, 2012

    Singapore: The International Court of Arbitration, International Chamber of Commerce, has issued its arbitral award in the arbitration filed by R-Tech Ueno, together with Sucampo Pharmaceut...Read more

  • APAC ovarian cancer drug market to grow modestly'

    Japan |  Analysis | By BioSpectrum Bureau  | 0 Comment | 30 Jan, 2015

    Singapore: Asia Pacific (APAC) therapeutics market for ovarian cancer will undergo a modest rise in value, from $294.3 million in 2013 to $417.6 million by 2020, at a Compound Annual Growth...Read more